In 2003, a study by Dr. Victoria Hendrick et al. titled “Birth outcomes after prenatal exposure to antidepressant medication” was published in The American Journal of Obstetrics and Gynecology, aiming to evaluate the risk for congenital malformations in infants whose mothers used antidepressant medication during pregnancy.

Using many different parameters and studying different antidepressant drugs individually, the Hendrick et al. team established that mothers who used Prozac® (fluoxetine) during pregnancy at a high dose placed infants at a dramatically-increased risk for low birth weight.[1]  In fact, all of the infants studied who were born at a low birth weight were born to mothers who had used a high dose of Prozac® during pregnancy.[2]

While this study does not illuminate the how Prozac® causes low birth weight, it goes great length to elucidate a strong, statistically significant correlation between high-dosage Prozac® use during pregnancy and low birth weight.  Unfortunately, the manufacturer of Prozac® does not include anything on its warning label about the risk for low birth weight, so it is possible that expecting mothers place their developing children at risk for birth defect through no fault of their own.

Because of this withholding of information regarding the danger of a pharmaceutical by its manufacturer, a number of Prozac® birth defect lawsuits and Prozac® low birth weight lawsuits are currently being filed.  If you used Prozac® during pregnancy and your child was born with a congenital malformation or with a low birth weight, please do not hesitate to contact our team of Prozac® birth defects lawyers.

At your convenience, you may reach us by phone at (855) 452-5529 or by e-mail at for a free, no-obligation case consultation.  We have the experience, resources, and skills required to win the justice your family deserves.

Our SSRI Birth Defects Lawsuit Information page is a great place to start if you have any questions about SSRIs and Birth Defects.

[1] Hendrick, V. et al. (2003) “Birth outcomes after prenatal exposure to antidepressant medication” Am J Obstet Gynecol 2003 Mar; 188(3): 812-5

[2] Ibid.